secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2024-05-23T23:59:59+00:00
Accession:  0001104659-24-064437
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics prices $600M 2.50% convertible notes due 2029; to repurchase $200M of 2026 notes
--------------------------------------------------------------------------------

- $600M 2.50% convertible senior notes due 2029 priced; initial conversion price ~$117.12/share (30% premium over $90.09 closing).
- Concurrently repurchasing $200M aggregate principal of 0.00% 2026 notes for $185.5M cash in privately negotiated transactions.
- Net proceeds estimated ~$584.8M; to repay $230M revolver, pay ~$75.6M for capped calls, and for general purposes.
- Capped call transactions entered to offset dilution, with initial cap price $180.18/share (~100% premium).
- Initial purchasers granted option to buy up to additional $100M principal amount of notes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000110465924064437/0001104659-24-064437-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000110465924064437/tm2415391d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-064437

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer